fda warning letter compounding semaglutide october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our The FDA has officially approved

L.FadoolA

Blood-sugar improvement may appear within 12 weeks, full effect in several months

FAQ What happens after I sign up for an evaluation

Danuglipron made it further to Phase IIb, but Pfizer ended the entire program in April 2025 after a single asymptomatic case of potential drug-induced liver injury and dropped its third oral candidate a few months later

To minimize risk of hypoglycemia, patients who were on sulfonylureas had their doses reduced by 50% at the discretion of the investigator, from randomization

About Biom Probiotics: Biom Pharmaceuticals is a pharmaceutical and functional food company focused on microbiome R & D and product development